# Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy

> **NCT03783182** · PHASE4 · RECRUITING · sponsor: **Umeå University** · enrollment: 100 (estimated)

## Conditions studied

- Tonsillectomy
- Pain
- PONV
- Bleeding

## Interventions

- **DRUG:** Betamethason Sodium Phosphate
- **DRUG:** 10% glucose solution

## Key facts

- **NCT ID:** NCT03783182
- **Lead sponsor:** Umeå University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-10
- **Primary completion:** 2025-06-20
- **Final completion:** 2025-12-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03783182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03783182, "Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT03783182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*